Peter Schwarzmann
Papers
3
Total Citations
78
H-Index
3
About
Peter Schwarzmann is a pioneering figure in telepathology, whose work has fundamentally shaped how digital and remote microscopy are integrated into diagnostic pathology, particularly in breast cancer care. His research centers on the clinical validation of telepathology as a reliable alternative to conventional histopathology, with a strong emphasis on quality assurance and diagnostic accuracy. Schwarzmann’s major contributions include leading pivotal clinical trials that demonstrated the feasibility of robotic telepathology for remote frozen section diagnosis and external quality assurance in breast histopathology. His most cited paper, a 2000 clinical trial (43 citations), established telepathology as a viable modality for the U.K. breast screening program, proving its clinical and technical utility. A subsequent 2000 study on ISDN-mediated remote microscopy (32 citations) further validated the accuracy of telepathological frozen section diagnosis. These achievements have laid the groundwork for modern digital pathology workflows, influencing both clinical practice and regulatory standards. Schwarzmann’s work remains a cornerstone for researchers and clinicians exploring remote diagnostics, showcasing how rigorous trial design can bridge technology and patient care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3